Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interstitial implant with interstitial hyperthermia

N Vora, B Forell, C Joseph

    Cancer
    |December 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Oral health care pathways for patients with epidermolysis bullosa: A position statement from the European reference network for rare skin diseases.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2024
    Same author

    Prevalence of secondary health conditions and mental status in persons with long-term spinal cord injury in South Africa: Comparison between public and private healthcare sectors.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2023
    Same author

    Self-reported beta-lactam allergy in government and private hospitals in Cape Town, South Africa.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2023
    Same author

    Improving delivery room and admission efficiency and outcomes for infants < 32 weeks: ELGAN+ (Extremely Low Gestational Age Neonate).

    Journal of neonatal-perinatal medicine·2023
    Same author

    Perception of Oral Health-Related Quality of Life in Children with Epidermolysis Bullosa: A Quantitative and Qualitative Study.

    JDR clinical and translational research·2022
    Same author

    Exploring the mylohyoid area as a reference for three-dimensional digital mandibular superimposition.

    Journal of stomatology, oral and maxillofacial surgery·2022
    Same journal

    Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.

    Cancer·2026
    Same journal

    Toward exercise as standard care for older cancer survivors.

    Cancer·2026
    Same journal

    Maintenance therapy in gynecologic malignancies: Current and future state.

    Cancer·2026
    Same journal

    Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

    Cancer·2026
    Same journal

    Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

    Cancer·2026
    Same journal

    EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

    Cancer·2026
    See all related articles

    Interstitial thermoradiotherapy combining radiofrequency hyperthermia and brachytherapy shows promise for advanced cancers. This pilot study found high complete response rates with minimal normal tissue complications in difficult-to-treat tumors.

    Area of Science:

    • Oncology
    • Radiation Oncology
    • Medical Physics

    Background:

    • Advanced or recurrent tumors often present challenges for conventional treatments.
    • Combining radiation therapy with hyperthermia is an area of research for enhancing treatment efficacy.
    • Interstitial and intracavitary brachytherapy offer localized radiation delivery.

    Purpose of the Study:

    • To evaluate the safety and efficacy of combining interstitial/intracavitary irradiation with interstitial hyperthermia.
    • To assess treatment response in patients with advanced or recurrent malignant tumors.
    • To determine normal tissue complication rates associated with this combined modality.

    Main Methods:

    • A Phase I pilot study involving 15 patients with 16 lesions.
    • Interstitial or intracavitary irradiation using 192Ir or 137Cs.

    Related Experiment Videos

  • Interstitial hyperthermia using 0.5 MHz radiofrequency localized current fields, maintaining 41-45°C for 30-40 minutes prior to irradiation.

    • Main Results:

    • 11 out of 16 lesions (68%) achieved complete response.
    • All six patients receiving interstitial implant and hyperthermia as primary therapy achieved complete response.
    • Normal tissue complications were minimal, with response durations ranging from 3 to 13 months.

    Conclusions:

    • Interstitial thermoradiotherapy is a safe and promising therapeutic option for advanced or recurrent accessible malignant tumors.
    • The combination of hyperthermia and brachytherapy demonstrates significant potential in managing challenging cancer cases.
    • Further investigation is warranted to establish the role of this combined modality in oncological treatment paradigms.